Episurf Medical’s Episealer® Knee implants included in UK NICE guidelines
Episurf Medical (NASDAQ: EPIS B) today announces that the UK National Institute for Health and Care Excellence (NICE) has on August 24 published interventional procedures guidance on IPG734 Focal resurfacing implants to treat articular cartilage damage in the knee, where Episurf Medical’s Episealer® Knee implants are included. The publication follows a review of relevant documentation and stakeholder input, including patients and surgeons, that has been going on for several quarters. NICE guidelines are evidence-based recommendations for health and care in the UK, to help healthcare